Trending...
- Hiclean Tools Releases HCX2100 Electric Pressure Washer
- Some Music for Donald's Bad Day
- Who plays xs in the flash and which episodes has her? "Schway!"
WEST HOLLYWOOD, Calif. - Californer -- Simufilam is a leading candidate to become the first effective treatment for Alzheimer's Disease. In an analysis by sfbanc financial, Cassava Sciences, Inc. (SAVA) was upgraded as a Strong Buy, from 8/10 to 9.5/10.
The drug in development purportedly works by retiring the proper conformation of filamin A, a molecule involved in the cascade of Alzheimer's disease. Open-label results are showing effectiveness in 84% of subjects treated. These promising results, along with recent insider buying, has led the sfbanc community to upgrade the stock.
More on The Californer
Additional results from the open label trial are expected by the end of this year. Call volume shows optimism for the results of the Cognitive Maintenance Study (CMS) in late 2023. This trial will include 100 subjects randomized to switch from active drug to placebo. Simufilam is currently in two randomized placebo-controlled Phase 3 trials.
sfbanc is a financial community that provides analysis and discussion of available public information in the finance sector. https://sfbanc.com
The drug in development purportedly works by retiring the proper conformation of filamin A, a molecule involved in the cascade of Alzheimer's disease. Open-label results are showing effectiveness in 84% of subjects treated. These promising results, along with recent insider buying, has led the sfbanc community to upgrade the stock.
More on The Californer
- BayWa r.e. Solar Trade and WHES Announce Distribution Partnership for the European Market: Delivering Smarter Energy Storage
- Governor Newsom outlines California's economic dominance at the California Economic Summit
- Fleet Mining Cloud Mining Platform — Latest Guide: Making Bitcoin Mining Safer and More Convenient
- Lightning Motorcycles Sets the Standard with Advanced 800V Architecture
- Update Any Sign Instantly with Santek EZ Sign NFC: Ultra-Slim 4-Color E-Paper Display
Additional results from the open label trial are expected by the end of this year. Call volume shows optimism for the results of the Cognitive Maintenance Study (CMS) in late 2023. This trial will include 100 subjects randomized to switch from active drug to placebo. Simufilam is currently in two randomized placebo-controlled Phase 3 trials.
sfbanc is a financial community that provides analysis and discussion of available public information in the finance sector. https://sfbanc.com
Source: sfbanc
1 Comment
- J Hautau:
SAVA🚀 no side effects. Promising.
Latest on The Californer
- Pepperdine University Malibu, California and Community Partners Recognized with 2025 ReadyCommunities Partnership National Service Award
- Promise B Mae's "Baddies R Us" Grand Opening Earns City Recognition, Cardi B Cosign & Support
- California expands CalAssist Mortgage Fund Disaster Relief: More California families to qualify for mortgage grants
- NBA Overachievers: OddsTrader Reveals Which Teams Will Exceed Expectations in 2025-26
- Crypto Betting Odds 2025: Bookmakers Review Analyzes Market Predictions and Year-End Price Lines
- The OpenSSL Corporation and the OpenSSL Foundation Celebrate the Success of the Inaugural OpenSSL Conference in Prague
- DJ Expert Warns Couples: "Bargain Wedding DJs Are Backing Out for Higher-Paying Gigs Leaving Clients Scrambling"
- California to deploy National Guard to support food banks, fast-track funding as Trump's shutdown strips families of food benefits
- Aaron Akins' 'When Do We Love Tour' Arrives in Los Angeles at Catalina Jazz Club Nov. 5, 2025
- TKL Group's New Factory Commences Production, Pioneering A New Era In Global Heavy Duty Truck Parts
- Regulated Crypto Exchange TZNXG Addresses Core US Market Challenges with Compliance-First Infrastructure
- GitKraken Launches Insights to Help Engineering Leaders Quantify AI Impact and Improve Developer Experience
- ZapperBox NextGen TV Gateway Receiver Now Testing Support For Secure Whole-Home Content Distribution
- Life as a Dog: P-Wave Press Brings Readers a Heartwarming Memoir of Love, Laughter and Companionship
- NOYA Launches Premium, Design-Forward Training Gear That Belongs at the Center of Your Space
- Tanbii Raises $3 Million to Launch Web3 Game Lets You Plant Virtual Trees and See Real Trees Grow
- Clear Winner Offers $100 Off New Window Installations in Palm Desert, CA
- 2 Pianos 4 Hands at North Coast Repertory Theatre
- Eisenhower: This Piece of Ground at North Coast Repertory Theatre
- Research Defense Examines Violence, Illiteracy, Non-Active Fathers, and Low Self-Esteem Among Males